« Back to Record
Bartlett, J. M. S., Poole, C., Shepherd, L., Cardoso, F., Jensen, M. B., Caldas, C., Twelves, C., Rea, D. W., Ejlertsen, B., Leo, A., Pritchard, K., McConkey, C. C., Munro, A., Desmedt, C., Dunn, J. J., Larsimont, D., O'Malley, F. P., Cameron, D. D., & Earl, H. (2015). Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also. Journal of clinical oncology, 33(15), 1680-1687. doi:10.1200/JCO.2013.54.7869
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/217323



